CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $391,200
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$391,200. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-25 | Kaplan Myron Director | Grant or award · Stock Option (Right to Buy Common Stock) | +15,000 | $5.63 | $84K | 15,000 |
| 2020-02-25 | Baluch Khoso Chief Executive Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +100,630 | $5.63 | $567K | 100,630 |
| 2020-02-25 | ARMSTRONG JR. JOHN L. Exec VP of Tech Operations | Grant or award · Stock Option (Right to Buy Common Stock) | +24,764 | $5.63 | $139K | 24,764 |
| 2020-02-25 | Masson Elizabeth EVP, Head of Clinical Ops. | Grant or award · Stock Option (Right to Buy Common Stock) | +24,764 | $5.63 | $139K | 24,764 |
| 2020-02-25 | DUNTON ALAN W Director | Grant or award · Stock Option (Right to Buy Common Stock) | +15,000 | $5.63 | $84K | 15,000 |
| 2020-02-14 | Dillione Janet Director | Grant or award · Phantom Stock | +1,706 | 1,706 | ||
| 2020-02-14 | Dillione Janet Director | Grant or award · Phantom Stock | +1,706 | 1,706 | ||
| 2020-01-07 | Lefkowitz Steven W Director | Option exercise | +4,500 | $4.50 | $20K | 59,776 |
| 2020-01-07 | Lefkowitz Steven W Director | Option exercise | +3,000 | $4.50 | $14K | 30,152 |
| 2020-01-07 | Lefkowitz Steven W Director | Option exercise · Warrant (Right to Purchase Common Stock) | +4,500 | $4.50 | $20K | 4,500 |
| 2020-01-07 | Lefkowitz Steven W Director | Option exercise · Warrant (Right to Purchase Common Stock) | +3,000 | $4.50 | $14K | 3,000 |
| 2019-12-30 | Mounts Phoebe General Counsel | Purchase | +1,425 | $7.04 | $10K | 1,425 |
| 2019-12-13 | Khan Mehmood Director | Purchase | +17,000 | $6.58 | $112K | 133,017 |
| 2019-11-14 | Dillione Janet Director | Grant or award · Phantom Stock | +2,099 | 2,099 | ||
| 2019-09-30 | Kaplan Myron Director | Purchase | +5,000 | $6.81 | $34K | 109,734 |
| 2019-09-30 | Cook Robert W. Chief Financial Officer | Purchase | +1,000 | $6.88 | $7K | 27,517 |
| 2019-09-27 | Lefkowitz Steven W Director | Purchase | +5,000 | $6.75 | $34K | 55,276 |
| 2019-09-26 | Baluch Khoso Chief Executive Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +120,000 | 120,000 | ||
| 2019-08-16 | Cook Robert W. Chief Financial Officer | Purchase | +1,000 | $8.18 | $8K | 26,517 |
| 2019-08-16 | Cook Robert W. Chief Financial Officer | Purchase | +1,000 | $8.18 | $8K | 26,517 |
Page 14 of 16 · 301 trades